Delcath Systems, Inc. (DCTH) Hit With Another FDA Setback
5/1/2013 9:17:02 AM
More...
|
Delcath Systems, Inc. (DCTH) Moving Headquarters to Queensbury, But Plans Job Cuts
4/10/2013 8:04:46 AM
More...
|
Delcath Systems, Inc. (DCTH) Raises $21 Million, Looks for Additional $50 Million
3/14/2013 10:18:16 AM
More...
|
Delcath Systems, Inc. (DCTH) Trims Queensbury Workforce as it Awaits FDA Approval
2/4/2013 8:23:11 AM
More...
|
Delcath Systems, Inc. (DCTH) Announces CE Marking for Hepatic CHEMOSAT® Delivery System for Use With Doxorubicin Injection
10/22/2012 8:25:12 AM
More...
|
Delcath Systems, Inc. (DCTH) Clears Important FDA Hurdle
10/17/2012 9:24:16 AM
More...
|
Delcath Systems, Inc. (DCTH) Submits New Drug Application for Proprietary Chemosaturation System to FDA
8/15/2012 10:02:52 AM
More...
|
Delcath Systems, Inc. (DCTH) to Present at Upcoming Investor Conferences
8/8/2012 12:28:27 PM
More...
|
Delcath Systems, Inc. (DCTH) Reports Second Quarter 2012 Financial Results and Highlights Recent Accomplishments
8/7/2012 12:07:05 PM
More...
|
Delcath Systems, Inc. (DCTH) to Conduct Second Quarter 2012 Results Conference Call
7/17/2012 11:45:32 AM
More...
|
|